What is the Projected CAGR value of the Orphan Drugs Market ?
The Global Orphan Drugs Market is estimated to reach at a CAGR of 11.2% during the forecast period 2024-2031.
Who are the key players in the Orphan Drugs Market ?
Major players are AbbVie Inc., Alexion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Roche Holding AG, Sanofi SA, and Shire plc.